The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Blood glucose concentration and outcome of critical illness: The impact of diabetes*
Abstract
Objective: To study the impact of diabetes mellitus on the relationship between glycemia and mortality in critically ill patients. Design: Retrospective observational study. Setting: Intensive care units of two university hospitals. Patients: Cohort of 4946 critically ill patients including 728 patients with diabetes mellitus. Intervention: None. Measurements and Main Results: We assessed and compared the relationship between glycemia during intensive care unit stay and mortality in diabetic and nondiabetic patients. There were 125,036 blood glucose measurements (5.7 measurements/day on average). Intensive care unit mortality increased significantly with increasing mean blood glucose concentration in nondiabetes mellitus patients but not in diabetes mellitus patients. Nondiabetes mellitus patients with a time-weighted glucose concentration (GluTw) between 8.0 and 10.0 mmol/L were found to be 1.74 times more likely to die in intensive care unit as diabetes mellitus patients in the same range (odds ratio = 1.74 [1.13–2.68] p = 0.01). They were also more than three times more likely to die in the intensive care unit compared with diabetes mellitus patients when the Glutw was between 10.0 and 11.1 mmol/L (odds ratio = 3.34 [1.35–8.23] p = 0.009). Using multivariate logistic regression analysis, hyperglycemia was strongly and independently associated with outcome in nondiabetic patients (p < 0.001) but showed no significant association with outcome in diabetic patients. Conclusions: Unlike nondiabetic patients, diabetic patients show no clear association between hyperglycemia during intensive care unit stay and mortality and markedly lower odds ratios of death at all levels of hyperglycemia. These findings suggest that, in critically patients with diabetes mellitus, hyperglycemia may have different biological and/or clinical implications. LEARNING OBJECTIVES On completion of this article, the reader should be able to: Explain the impact of blood glucose monitoring on outcomes. Describe the impact of the diagnosis of diabetes on outcomes in patients with hyperglycemia. Use this information in a clinical setting. Dr. French has disclosed that he was the recipient of grant/research funds from Novartis and is currently receiving grant/research funds from Novartis, Wyeth, Lilly, and Takeda. Dr. French has disclosed that he was a consultant/advisor for Wyeth. The remaining authors have disclosed that they have no financial relationships with or interests in any commercial companies pertaining to this educational activity. All faculty and staff in a position to control the content of this CME activity have disclosed that they have no financial relationship with, or financial interests in, any commercial companies pertaining to this educational activity. Lippincott CME Institute, Inc., has identified and resolved all faculty conflicts of interest regarding this educational activity. Visit the Critical Care Medicine Web Site (www.ccmjournal.org) for information on obtaining continuing medical education credit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“In these trials, IIT was reported to reduce mortality and morbidity in ventilated surgical patients (7) and in medical patients staying in the ICU for longer than 3 days (8).”
BackgroundResultInfluentialMalmberg, K., Rydén, L., Efendic, S., Herlitz, J., Nicol, P., Waldenstrom, A., Wedel, H., & Welin, L. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00126-k · Cited by 1,560
Malmberg, K. (1997) · BMJ · doi:10.1136/bmj.314.7093.1512 · Cited by 1,286
Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult Patients
Krinsley, J. S. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.8.992 · Cited by 1,223
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130
Glucose Control and Mortality in Critically Ill Patients
Finney, S. J. (2003) · JAMA · doi:10.1001/jama.290.15.2041 · Cited by 1,055
Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients
Egi, M., Bellomo, R., Stachowski, E., French, C. J., & Hart, G. (2006) · Anesthesiology · doi:10.1097/00000542-200608000-00006 · Cited by 854
Self-citationLazar, H. L., Chipkin, S. R., Fitzgerald, C. A., Bao, Y., Cabral, H., & Apstein, C. S. (2004) · Circulation · doi:10.1161/01.cir.0000121747.71054.79 · Cited by 717
Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units
Van den Berghe, G., Wilmer, A., Milants, I., Wouters, P. J., Bouckaert, B., Bruyninckx, F., Bouillon, R., & Schetz, M. (2006) · Diabetes · doi:10.2337/db06-0855 · Cited by 599
Glucose metabolism in man: Responses to intravenous glucose infusion
Wolfe, R. R., Allsop, J. R., & Burke, J. F. (1979) · Metabolism · doi:10.1016/0026-0495(79)90066-0 · Cited by 365
Stow, P. J., Hart, G. K., Higlett, T., George, C., Herkes, R., McWilliam, D., & Bellomo, R. (2006) · Journal of Critical Care · doi:10.1016/j.jcrc.2005.11.010 · Cited by 272
Self-citationRady, M. Y., Johnson, D. J., Patel, B. M., Larson, J. S., & Helmers, R. A. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.12.1558 · Cited by 198
Differentiation between septic and postburn insulin resistance
Shangraw, R. E., Jahoor, F., Miyoshi, H., Neff, W. A., Stuart, C. A., Herndon, D. N., & Wolfe, R. R. (1989) · Metabolism · doi:10.1016/0026-0495(89)90010-3 · Cited by 185
Insulin Resistance and Hyperglycemia in Critical Illness: Role of Insulin in Glycemic Control
Robinson, L. E., & van Soeren, M. H. (2004) · AACN Clinical Issues: Advanced Practice in Acute and Critical Care · doi:10.1097/00044067-200401000-00004 · Cited by 173
An Insulin Infusion Protocol in Critically Ill Cardiothoracic Surgery Patients
Zimmerman, C. R., Mlynarek, M. E., Jordan, J., Rajda, C. A., & Horst, H. M. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e018 · Cited by 128
Impact of diabetes mellitus on cardiac surgery outcome
Bucerius, J., Gummert, J., Walther, T., Doll, N., Falk, V., Onnasch, J., Barten, M., & Mohr, F. (2004) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-2003-37280 · Cited by 120
Perioperative diabetic and hyperglycemic management issues
Coursin, D. B., Connery, L. E., & Ketzler, J. T. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000115623.52021.c0 · Cited by 109
Glycemic Control in the Intensive Care Unit: Why We Should Wait for NICE-SUGAR
Bellomo, R., & Egi, M. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.12.1546 · Cited by 98
Self-citationCollier, B. C., Diaz, J. J., Forbes, R. C., Morris, J. A., May, A. K., Guy, J. S., Özdaş, A., Dupont, W. D., Miller, R. S., & Jensen, G. L. (2005) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607105029005353 · Cited by 81
Mitchell, I., Knight, E., Gissane, J., Tamhane, R., Kolli, R., Leditschke, I. A., Bellomo, R., & Finfer, S. R. (2006) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)02060-4 · Cited by 53
Self-citationGitt, A., Schiele, R., Wienbergen, H., Zeymer, U., Schneider, S., Gottwik, M., & Senges, J. (2003) · Acta Diabetologica · doi:10.1007/s00592-003-0117-8 · Cited by 39
Glycemic Control in Critically Ill Patients
Krinsley, J. S. (2007) · CHEST Journal · doi:10.1378/chest.07-0834 · Cited by 35
Rethinking glycaemic control in critical illness — from concept to clinical practice change
Shaw, G. M., Chase, J. G., Wong, J., Lin, J., Lotz, T., Compte, A. J. L., Lonergan, T., Willacy, M., & Hann, C. E. (2006) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01420-5 · Cited by 25
Orford, N. R., Stow, P. J., Green, D., & Corke, C. F. (2004) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01869-0 · Cited by 23
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citationSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Self-citationDungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Metadata
- Authors
- Egi, M., Bellomo, R., Stachowski, E., French, C. J., Hart, G. K., Hegarty, C., & Bailey, M.
- Venue
- Critical Care Medicine
- Published
- 2008-08
- Volume
- 36
- Issue
- 8
- Pages
- 2249-2255
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2046512232
- Cited by
- 399
- References
- 27
- FWCI
- 19.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.